Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L7 like 1 (RPL7L1) is a structural protein component of the cytosolic large (60S) subunit of the eukaryotic ribosome, predicted to enable RNA binding and contribute to ribosome assembly and maturation of large subunit rRNA[1][3][4][6][7]. It belongs to the large ribosomal subunit protein uL30 family, but current data do not indicate direct involvement as a therapeutic drug target or biomarker, nor are there known safety or therapeutic concerns associated with its modulation in humans.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L7 like 1 (RPL7L1).